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Background. Early detection and diagnosis of tuberculosis (TB) and the timely commencement of antituberculosis (anti-TB)
treatment are the parts of efficient tuberculosis prevention and control program. Delay in the commencement of anti-TB treatment
worsens the prognosis and increases the risk of death and the chance of transmission in the community and among health care
workers. Objective. To assess tuberculosis treatment delay and associated factors among pulmonary TB patients in Addis Ababa,
Ethiopia. Methods. A cross-sectional study was conducted in 10 public and 10 private health facilities that provide TB treatment.
The data were collected from 425 newly registered pulmonary TB patients using pretested structured questionnaire from April to
June 2012. Data were entered in EPI info version 3.5.1 and analyzed using SPSS version 16.0. Findings. The median durations of a
patient, health care system, and total treatment delays were 17, 9, and 35 days, respectively. Overall 179 (42.1%), 233 (54.8%), and 262
(61.6%) of patients experienced patient delay, health care system delay, and total treatment delay, respectively. Distance more than
2.5 km from TB treatment health facility [AOR = 1.6, 95% CI (1.1–2.5)] and the presence of TB-associated stigma [AOR = 2.1, 95%
CI (1.3, 3.4)] indicate higher odds of patient delay, whereas, being unemployed, patients with the hemoptysis symptom complain
indicated lower odds of health care system delay [AOR = 0.41, 95% CI (0.24, 0.70)] and [AOR = 0.61 (0.39, 0.94)], respectively.
Conclusions. A significant proportion of clients experienced patient and health care system delay.Thus, there is a need for designing
and implementing appropriate strategies to decrease the delays. Efforts to reduce delays should give focus on integrating prevention
programs such as active case detection and expanding access to TB care.
1. Introduction
According to WHO global tuberculosis report of 2012,
tuberculosis (TB) affects the age group of 15 to 59 years
old, which is an economically productive age group, and
there were 8.7 million incident cases [range: 8.3 million–
9.0 million] globally, equivalent to 125 cases per 100,000
population, and approximately 1.4 million died of TB in the
year 2011 of whom 0.5 million were women. Most of the
estimated number of cases in 2011 occurred in Asia (59%)
and Africa (26%). The 22 high burden countries accounted
for 81% of all estimated cases worldwide [1], where Ethiopia
ranks seventh with an estimated incidence of all forms of TB
of 378 new cases per 100,000 pop/year and 163 new smear-
positive cases per 100,000 pop/year.The estimated prevalence
of all forms of TB is 579/100,000 population, and smear-
positive TB was 286/100,000 pop [1, 2]. The global target for
TB control through full Directly Observed Treatment Short
(DOTS) course expansion was the attainment of 70% case
detection and attainment of 85% cure rate by 2005 [1, 3]. The
Ethiopia DOTS detection rate was 36 percent, which is far
behind the WHO’s target of 70 percent detection [3].
Although different factors contribute to the low detection
rate, studies conducted in different parts of the country
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indicated the patient delay in seeking treatment to be the
main reason for high transmission and low detection rate [4–
6]. The patient delay in seeking TB treatment together with
health facility delay and referral delay leads to the treatment
delay. Early diagnosis of the disease and prompt initiation
of the treatment are essential for an effective tuberculosis
control program. Delay in the initiation of tuberculosis treat-
ment further increases the burden of tuberculosis by raising
the probability of patients transmitting the infection and
speeding up the emergence and transmission of multidrug-
resistant (MDR) tuberculosis [1, 4–7]. Most transmissions
occur from the onset of a cough to the initiation of treatment
[8]. It is estimated that a patient with untreated smear-
positive pulmonary TB may infect on average more than
10 persons per year and over 20 persons until death [1,
2]. Smear-negative pulmonary TB also plays a role in the
spread of infection [1, 3]. Additionally, delay in initiation of
tuberculosis treatment worsens the prognosis and increases
the risk of death [1, 3, 4]. The treatment delay affects
an individual, the community, and a country’s health and
economy [1]. In general, it is very difficult to quantify the
crisis in country’s health and economy, especially in the
era of MDR-TB, from suffering and death of economically
productive individuals from such preventable and treatable
disease because of delayed initiation of treatment [1, 8].
In Ethiopia, studies on treatment delay among pulmonary
patients are scarce. Likewise, recent information on treatment
delay is highly limited especially in an urban setting, and
unlike the previous studies, this study was conducted with
pulmonary TB patients from both public and private facilities
[4–6]. TB prevention and control is among the biggest
public health challenges Ethiopia is facing. If the control
of tuberculosis must succeed, magnitude and causes of the
patient, health care system, and total treatment delays should
further be investigated and curtailed. Hence, the purpose
of this study was to investigate the magnitude and factors
associated with the patient, health care system, and total
treatment delays among pulmonary tuberculosis patients in
Addis Ababa, Ethiopia.
2. Methods and Materials
2.1. Study Settings and Participants. The study was conducted
in Addis Ababa city administration (capital of Ethiopia). The
city has 10 subcities and a total population of 2.7 million. In
the city, there were 24 public health centers and 25 private
facilities providing TB treatment using DOTS program at the
time of the study. A cross-sectional study was conducted in 10
public and 10 private DOTS-providing health facilities from
April 3, 2012, to June 7, 2012. Both smear-positive and smear-
negative pulmonary TB patients aged 15 years and above were
included in the study. Relapse, failure, defaulters, and transfer
in patients were excluded from the study since it is difficult
to ascertain the date of the onset of symptoms and measure
knowledge in these groups of patients. Additionally, patients
who are severely ill were also excluded from the study.
2.2. Sample Size Determination. Single population propor-
tion estimation formula was used with an assumption of 95%
confidence interval, 5% significance level, 5%margin of error,
10% nonresponse rate, and 48% proportion of patient delay
from a study conducted in Amhara region Ethiopia in 2005
[10]. Thus, the total sample size was 422.
2.3. Sampling Technique and Procedures. At the beginning
of the study, 10 public health centers and 10 private health
facilities were selected from 24 health centers and 25 private
clinics, respectively. The selection of the health facilities was
made from 10 subcities in Addis Ababa, and to ensure fair
representation of each subcity, one public health center and
one private health facility were selected randomly from the
available public health centers and private health facilities in
each subcity. Proportional allocation of patients according
to the expected size of TB patients who seek care at each
health facility was undertaken after reviewing previous years
TB registries. Then, all pulmonary TB patients who were
newly diagnosed and started anti-TB treatment during the
study period were consecutively included in the study until
the intended sample size was achieved.
2.4. Data Collection Instrument and Procedures. The data
were collected from patients on the same day of initiation
of anti-TB treatment by using an interviewer administered,
locally translated (Amharic) questionnaire. The question-
naire was adopted with little modification from the WHO
multicountry tuberculosis treatment delay survey and WHO
ASSIST guideline [9, 11]. Data collectors were treatment
providers working in the same health institutions. Adequate
trainingwas given for data collectors for 2 days on the content
of the questionnaire and consent forms.
2.5. DataQuality Assurance. Thequestionnaire was pretested
on 5% of the sample size in Addis Ababa in similar health
facilities, which were not included in the sample and nec-
essary modifications were made whenever needed. Frequent
supervision of the data collection sites was made by the
principal investigator and the assigned supervisors. Data
collectors and supervisors checked the data for completeness
and consistency daily. Completed quantitative data were
entered into EPI info version 3.5.1 software. Then data were
exported to SPSS version 16.0 and checked for inconsisten-
cies and missing values by running frequencies and other
data explorations. Inconsistencies and missing values were
cleaned by checking the original questionnaire.
2.6. Data Analysis and Presentation. Description statistics
such as mean, median, standard deviation, and percent were
used to describe descriptive variables. Binary logistic regres-
sion was employed to investigate the association between
independent variables and the outcome variables. Variables
that showed significant association with the delays in the
binary logistic regression at 𝑃 value ≤ 0.25 were included
in the multivariable logistic regression models to identify
independent predictors to patient delay and health care
system delay. In the multiple logistic regression models, the
model association was considered at 𝑃 value ≤ 0.05.
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Figure 1: Components of different delay periods from the onset of
symptom to the commencement of treatment. Modified fromWHO
diagnosis and treatment delay study [9].
2.6.1. Operational Definitions
The Onset of Symptom. It is the day when the patient first
becomes aware of the symptom or symptoms.
Patient Delay. Patient delay is the time interval from the first
onset of symptom to the first visit to health center or hospital
or private clinics, and time longer than 21 dayswas considered
indicative of patient delay [6, 7, 12, 13].
Health Care System Delay. Health care system delay is the
time interval from the patient’s first visit to the health center,
hospital, or private clinic to the commencement of treatment,
and time longer than 7 days is considered indicative of patient
delay [6, 7, 12, 13].
Total Treatment Delay. Total treatment delay is the time inter-
val from the first onset of symptom to the commencement of
treatment or the sum of patient delay and health care system
delay (Figure 1).
Knowledge.Variablesmeasuring knowledgewere recorded on
a 3-point Likert scale of 10 questions (3 best and 1 worst).
These included knowledge about the type of disease, its
causes, curability, and type of antituberculosis drugs and
duration of treatment. Patients who scored more than set
average (50%)were considered knowledgeable and thosewho
scored less than average were considered not knowledgeable
[9].
TB-Associated Stigma. Variables measuring stigma were
recorded on a 5-point Likert scale of 10 questions (5 the
highest and 1 the lowest degree of stigma). These variables
included feeling ashamed of having tuberculosis; having to
hide tuberculosis diagnosis from others; delay to seek treat-
ment due to fear of being diagnosed with TB; isolation due
to tuberculosis; tuberculosis affecting the relationship with
others; fear of TB/HIV coinfection. Patients who scoredmore
than set average (50%) were considered to be having a high
TB-associated stigma and those who scored less than average
were considered to be having a low TB-associated stigma [9].
2.7. Ethical Consideration. Ethical approval was obtained
from Jimma University Ethical Review Committee. Verbal
consent from respondents was obtained before conducting
the face-to-face interview. In order to maintain privacy and
avoid the fear of stigmatization, health professionals working
in TB units who already knew the serostatus of the clients
were assigned to be data collectors. Patients were assured that
the interview is private and confidential, their participation
is voluntary, and their names will not be included in the
questionnaire. Data collectors were provided proper advice
for the respondents regarding any malpractice they have
come across after the interview is completed.
3. Results
3.1. Patients Sociodemographic Characteristics. A total of 425
new smear-positive and smear-negative pulmonary tuber-
culosis (PTB) patients were consecutively included in the
studywith a response rate of 99.76%.Among the respondents,
237 (55.8%) were males, and 188 (44.2%) were females.
The majority of the respondents accounting for 251 (59.1%)
patients were in the age group of 15–34, and the mean age
was 33.9 years, 320 (75.2%) were Christians, 188 (44.2%)
were single, 176 (41.4%) were married, and 185 (43.5%) had
primary education (Grades 1–8). Occupationally, 190 (44.7%)
were employed. The majority of the patient’s family income
was between 15 and 45 USD (Table 1).
3.2. Clinical Characteristics and Health Seeking Behavior of
Patients. There were 241 (56.7%) smear-positive and 184
(43.3%) smear-negative pulmonary TB patients.The primary
symptoms that patients experienced during the onset of their
illness included coughing 411 (96.7%), followed by loss of
appetite 351 (82.6%) and fever 347 (81.6). A total of 218 (35%)
of patients tried different forms of self-treatment at home
and 334 (78.6%) patients were working in functional status
before contacting formal health facility. In general, 218 (51.55)
of patients first contacted public health facility, 302 (71.1%)
patients were given drugs other than anti-TB drugs during
their first visit to a health facility, 196 (46.1%) made at least
two visits before diagnosis was made, and 263 (61.8) patients
were diagnosed at public health facilities (Table 2).
3.3. Patient Delay. Overall 179 (42.1%) of patients did seek
medical advice after 21 days (SD = 26.9) of the onset of
their illness. The median patient delay was 17 days (IQR: 9–
33) and the mean patient delay was 26 days (SD = 26.9). A
total of 14 patients came on the same day of the onset of
symptom.Theminimumandmaximumdelays were 1 and 187
days, respectively. A total 382 patients (90%) camewithin two
months and 15 patients (4.5%) came after 90 days.
Patients who traveled a distancemore than 2.5 km to a TB
treatment health facility were 1.6 times more likely to delay
more than 21 days to contact a health facility when compared
to patients who traveled a distance less than 2.5 Km (AOR =
1.6, 95% CI: (1.1, 2.5)).
Similarly, patients with high TB-associated stigma were
2.2 times more likely to delay more than 21 days to contact a
health facility when comparedwith lowTB-associated stigma
(AOR = 2.1, 95% CI: [1.3, 3.4]) (Table 3).
3.4. Health Care System Delay. A total 233 (54.8%) pul-
monary TB patients had a health care system delay of more
than 7 days; of this, 136 patients (58.4%) first seek care at the
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Table 1: Sociodemographic characteristics of pulmonary TB
patients, Addis Ababa, Ethiopia, 2012.
Variables 𝑁 (%)
Sex
Male 237 (55.7)
Female 188 (44.2)
Age in years
15–24 119 (28)
25–34 132 (31)
35–44 88 (21)
45–54 49 (11.4)
55–64 22 (5.2)
65+ 15 (3.5)
Educational status
Unable to read and write 29 (6.8)
Able to read and write 39 (9.2)
Elementary (1–8) 185 (43.5)
Secondary (9–12) 104 (24.5)
Above secondary 68 (16)
Marital status
Single 188 (44.3)
Married 176 (41.5)
Divorced 28 (6.6)
Widowed 33 (7.8)
Occupational status
Employed 190 (44.7)
Unemployed 122 (28.7)
Housewife 42 (9.9)
Student 29 (6.8)
Merchant 34 (8)
Farmer 8 (1.87)
Religion
Christian 320 (75.2)
Muslim 104 (24.4)
Family income
<15 USDa 126 (29.6)
15–45 USD 210 (49.4)
>45 USD 89 (20.9)
a
1 USD = 18.22 ETB.
public health facility and 97 (41.6) at the private health facility.
The median health care system delay was 9 days (IQR: 3–
29), and the mean was 19 days (SD = 22.9). The minimum
and maximum health care system delays were 1 and 123 days,
respectively. Exactly 101 (23.8%) patients delayed more than a
month to start treatment, that is, 4 times the acceptable level
of health care system delay (Table 4). In multiple variable
logistic regression, patients with the symptom hemoptysis
and being unemployed in occupation were less likely to
experience health care system delay of more than 7 days once
they contacted a health facility for their presenting symptom
Table 2: Clinical characteristics and health seeking behavior pul-
monary TB patients in Addis Ababa, Ethiopia, 2012.
Patient characteristics Number(%)
TB category
Smear positive 241 (56.7)
Smear negative 184 (43.3)
Type of symptom
Cough 411 (96.7)
Loss of appetite 351 (82.6)
Fever 347 (81.6)
Night sweating 286 (67.3)
Chest pain 263 (61.9)
Haemoptysis 168 (39.5)
Loss of weight 49 (11.5)
HIV status
Positive 105 (24.7)
Negative 320 (75.3)
Contact history in the last 1 year
Yes 96 (22.6)
No 329 (77.4)
Self-treatment
Yes 149 (35.1)
No 276 (64.9)
Point of the first contact
Public health facility 218 (51.3)
Private health facility 134 (31.5)
Drug outlets 45 (11.5)
Traditional healer 28 (6.5)
Severity of disease at the 1st contact
Working 334 (78.6)
Ambulatory 86 (20.2)
Bed ridden 5 (1.2)
Services obtained at the 1st contact
Advice only 6 (1.4)
Sputum is taken for examination 186 (43.8)
X-ray examination 199 (46.8)
Non-Anti TB drug given 302 (71.1)
Referred to a higher level 1 (0.2)
Total number of health-seeking encounters before
diagnosis
One 151 (35.5)
Two 196 (46.1)
More than two 78 (18.4)
Place of diagnosis
Public health facility 263 (61.8)
Private health facility 162 (38.2)
(AOR = 0.41, 95% CI (0.24, 0.70) and 0.61 (0.39, 0.94)),
respectively (Table 4).
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Table 3: Factors associated with patient delay for treatment of PTB among pulmonary TB patients, Addis Ababa, 2012.
Variables Patient delay Unadjusted and adjusted OR
No delay Delay COR (95% CI) AOR (95% CI)
Educational status
Unable to read & write 12 17 1.2 (0.49, 3.0) 1.3 (0.48, 3.9)
Able to read & write 19 20 1.33 (0.61, 2.94) 0.55 (0.21, 1.5)
Elementary (1–8) 115 70 0.77 (0.44, 1.35) 0.93 (0.46, 1.9)
Secondary (9–12) 62 42 0.86 (0.46, 1.59) 0.77 (0.36, 1.7)
Above secondary 38 30 1 1
Marital status
Single 121 67 1 1
Married 94 82 1.58 (1.0, 2.4) 1.0 (0.61, 1.6)
Widowed 14 14 1.81 (0.81, 4.01) 1.4 (0.56, 3.6)
Divorced 17 16 1.70 (0.80, 3.5) 1.7 (0.75, 3.8)
Occupational status
Employed 109 81 1 1
Unemployed 74 48 0.87 (0.54, 1.39) 0.68 (0.40, 1.2)
Student 27 15 0.75 (0.37, 1.50) 0.82 (0.37, 1.8)
Housewife 15 14 1.26 (0.57, 2.75) 1.1 (0.46, 2.6)
Merchant 18 16 1.20 (0.57, 2.49) 1.2 (0.55, 2.6)
Farmer 3 5 2.24 (0.52, 9.66) 2.3 (0.48, 11.6)
Family size
>5 27 31 1.7 (0.97, 2.9) 1.7 (0.93, 3.2)
≤5 219 148 1 1
Type of symptom
Loss of weight
Yes 36 13 0.456 (0.23, 0.88)∗ 0.60 (0.28, 1.2)
No 210 166 1 1
Night sweating
Yes 177 109 0.60 (0.40, 0.91)∗ 0.70 (0.39, 1.24)
No 69 70 1 1
Loss of appetite
Yes 212 139 0.49 (0.29, 0.82)∗ 0.72 (0.45, 1.2)
No 34 40 1 1
Point of first contact
Traditional 10 18 3.11 (1.37, 7.05)∗ 0.38 (0.12, 1.2)
Drug out let 29 16 0.95 (0.49, 1.86) 0.78 (0.30, 2.0)
Private facility 69 65 1.63 (1.05, 2.51)∗ 0.59 (0.23, 1.5)
Public facility 138 80 1 1
Distance to health facility
>2.5 km 147 76 1.4 (0.98, 2.0) 1.6 (1.1, 2.5)∗
≤2.5 km 278 103 1 1
TB associated stigma
High stigma 127 129 2.4 (1.6, 3.6)∗∗ 2.1 (1.3, 3.4)∗
Low stigma 119 50 1 1
Knowledge
Not knowledgeable 176 113 0.68 (0.45, 1.04) 1.2 (0.80, 2.0)
Knowledgeable 65 61 1 1
∗
𝑃 value < 0.05; ∗∗𝑃 value <0.001; COR: crude odds ratio; AOR: adjusted odds ratio.
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Table 4: Factors associated with health care system delay for treatment of pulmonary TB among pulmonary TB patients, Addis Ababa,
Ethiopia, 2012.
Variables Health care system delay Unadjusted and adjusted OR
No delay Delay COR (95% CI) AOR (95% CI)
Sex
Male 100 137 1 1
Female 92 96 0.76 (0.52, 1.12) 0.86 (0.56, 1.3)
Educational status
Unable to read & write 13 16 1.16 (0.48, 2.78) 0.93 (0.35, 2.5)
Able to read and write 27 12 0.42 (0.18, 0.96) 0.89 (0.37, 2.1)
Elementary (1–8) 107 78 0.69 (0.39, 1.20) 1.1 (0.61, 2.1)
Secondary (9–12) 66 38 0.53 (0.28, 1.0) 1.2 (0.63, 2.4)
Above secondary 33 35 1 1
Occupational status
Employed 76 114 1 1
Unemployed 74 48 0.43 (0.27, 0.68)∗∗ 0.41 (0.24, 0.70)∗∗
Student 11 31 1.8 (0.89, 3.9) 2.1 (0.91, 4.6)
House wife 14 15 0.71 (0.32, 1.6) 0.55 (0.23, 1.3)
Merchant 15 19 0.84 (0.40, 1.8) 0.73 (0.34, 1.6)
Farmer 2 6 2 (0.39, 10.1) 1.8 (0.34, 10)
Marital status
Single 92 96 1 1
Married 68 108 1.5 (1.0, 2.3) 1.5 (0.91, 2.4)
Widowed 17 11 0.62 (0.27, 1.4) 1.0 (0.41, 2.5)
Divorced 15 18 1.15 (0.55, 2.4) 1.2 (0.55, 2.8)
Family size
≤5 171 196 1 1
>5 21 37 1.54 (0.87, 2.7) 1.7 (0.89, 3.2)
Type of symptom
Loss of weight
Yes 27 22 0.64 (0.35, 1.1) 0.85 (0.43, 1.7)
No 165 211 1 1
Haemoptysis
Yes 88 80 0.62 (0.41, 0.92)∗ 0.61 (0.39, 0.94)∗
No 104 153 1
Loss of appetite
Yes 167 184 0.56 (0.33, 0.95)∗ 0.56 (0.30, 1.02)
No 25 49 1 1
Health facility first contacted
Public health facility 123 136 1 1
Private health facility 69 97 1.3 (0.85, 1.8) 1.1 (0.70, 1.7)
TB associated stigma
Low stigma 87 82 1 1
High stigma 105 151 1.5 (1.03, 2.2)∗ 1.4 (0.90, 2.2)
Knowledge
Not knowledgeable 48 78 1.5 (0.96, 2.3) 1.5 (0.93, 2.4)
Knowledgeable 138 151 1
∗
𝑃 value < 0.05; ∗∗𝑃 value < 0.001, COR: Crude odds ratio, AOR: Adjusted odds ratio.
3.5. Total TB Treatment Delay. The median total treatment
delay was 35 days (IQR: 19–63) and the mean was 45 days
(SD = 35); the minimum andmaximum total treatment delay
were 2 days and 213 days, respectively. A total of 262 patients
(61.6%) delayed more than 28 days before the initiation of
treatment.
4. Discussion
This study shows that there is a significant delay from the
onset of symptoms to the first contact to a health facility and
from the first contact to initiation of anti-TB treatment for
pulmonary tuberculosis patients in Addis Ababa.
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Though the median patient delay of 17 days observed in
this study is the acceptable level of patient delay [7, 13, 14],
a significant proportion (41.2%) of TB patients experienced
a patient delay of more than 21 days. This means that the
substantial portion of TB patients in this study area did not
go to health facilities early.Therefore, these groups of patients
continued to serve as reservoirs of infection and will have
continued to transmit the disease in the community until
diagnosed and treated, which may have increased the burden
of TB. The finding of this study is similar to other studies
conducted in Ethiopia [4, 15] where a significant number of
patients delayed contacting a health facility for more than
21 days. This study also showed a median patient delay
lower than one in the findings of other studies conducted
in Ethiopia [4, 6, 15] that showed a median patient delay
of 28 to 56 days. This may be explained by the health care
service access; these studies were conducted in the rural
parts of Ethiopia where health seeking is believed to be low.
Additionally, the median patient delay documented in this
study was also lower than the one in the study conducted
in Addis Ababa a decade ago, which reported a median
patient delay of 60 days [5]. This can be explained by the TB
prevention and control measures taken in the last 10 years.
The median patient delay observed in our study is similar to
ones in studies conducted in Vietnam [16], Hong Kong [17],
and South India [18], where the reportedmedian patient delay
was between 14 and 21 days.
TB-associated stigma was one of the factors associated
with a patient delay. Patients with a high level of TB-
associated stigma were more likely to delay when compared
to the patients with low TB-associated stigma. TB-associated
stigma may have played an important role in hindering
patients from seeking early health care due to fear of being
diagnosed with TB. This finding is similar to discoveries
in other studies conducted in Yemen, Syria, and Somalia
[9]. Another variable that is associated with a longer patient
delay was a distance greater than 2.5 km from TB treatment
facility. This is because patients who came to a health facility
from a distance more than 2.5 are from a relatively distant
area from the health facility and this may create difficulties
in accessing a health facility. Distance has proved to be an
important factor for patient delay in studies conducted in
Ethiopia [15] and South India [18]. Patient delay was not
found significantly associated with age and sex in this study.
Similar findings were reported in Ethiopia [6, 15], Gambia
[19], Brazil [20], and Southern Taiwan [21]. However, studies
conducted in Ethiopia [4], SouthAfrica [22], South India [18],
and Thailand [23] reported that females tend to seek health
care lately compared to males. Similarly, older age was found
significantly associated with patient delay in Ethiopia [15],
South India [18], and Southern Taiwan [21].
It was observed that more than half of the patients
experience a health care system delay. The median health
care system delay of 9 days was documented in this study.
Likewise, a health care system delay between 6 and 11 days
was reported in studies conducted in Ethiopia [5] Nigeria
[24], and Vietnam [16]. The median health care system delay
documented in this study is lower than the findings of other
studies conducted in different parts of Ethiopia [4, 6, 15].
These differences could be due to study area where the
studies were conducted. Unlike this study, other studies are
conducted in rural part of Ethiopia where health service
coverage is low and available facilities may have limitations
in the diagnosis of TB like lack of facilities for sputum
examination, X-ray, and other supportive labs.
The median and magnitude of health care system delay
observed in this study were unacceptably high. This may
further increase the chance of transmission of TB in the
community and to health professionals as well. Researches
revealed that HIV or other immunesuppressing conditions
often produce an atypical TB presentation that can weaken a
patient’s or their clinician’s ability to detect TB, thus resulting
in a diagnostic delay. In our study information was collected
regarding comorbidities like HIV, even though the variable
did not appear as being significantly associated with the
delays.
Patients with the symptom hemoptysis were less likely to
experience health care system delay more than 7 days. This
may be explained by the fact that the symptom hemoptysis
will easily remind health providers in TB diagnosis since it
is a more serious symptom. Similar findings were reported in
Indonesia andNigeria [19, 25].Unemployed patientswere less
likely to experience a health care system delay. This might be
explained by assuming that unemployed people have enough
time to revisit health facilities and to respect appointments
given by health professionals for reevaluation.
Even though the association between health care system
delay and the type of health facility first contacted disap-
peared after being controlled for other factors, it was found
to be associated during binary logistic regression in this
study. A similar finding is reported in West Ethiopia [4]
andUganda [26]. However, other studies reported contacting
private clinic and health center in Ethiopia [6] and contacting
the private facility in India [18] which were found associated
with longer health care system delay. Hence, special attention
should be paid for treatment seeking behavior of patients.
Limitation of Study. The current study has limitations that
should be acknowledged. The recall bias might have been
introduced as patientsmay not accurately estimate or remem-
ber the exact date of the onset of the first symptom and
the date of the first visit made to a health facility. However,
holidays and spiritual days were used as a reminder during
the interview to minimize this bias. No information was
collected to determine the length of time from the partic-
ipants’ first presentation of symptoms to the time of the
interview. Information was not obtained for the time from
the respondents first presentation of symptom to the time of
interview. As there is no still agreed standard definition of
delays in the treatment of TB, interpretations should bemade
cautiously.
5. Conclusions
In this study, it was observed that a significant proportion of
patients delayed more than the acceptable level for patient
and health care system delay. The study identified that a
substantial proportion of TB patients in this study area did
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not get to health facilities early. Distance more than 2.5 km
from TB treatment facility and high TB-associated stigma
were found to be risk factors for prolonged patient delay. The
hemoptysis symptom and unemployed occupational status
were found to be protective factors not to experience longer
health care system delay.
Based on findings of this study, it is the time to design
active case detection strategies like TB screening of family
members and community level suspect identification by
using health extensionworkers to support the existing passive
case detection strategy and decrease the length of patient
delay. Moreover, it is important to increase the accessibility of
TB diagnosis and treatment services by involving the remain-
ing public health centers and private health facilities where
TB services have not yet started. It is noted that distance
between the patients’ homes to a TB treatment facility had
contributed to the delay in healthcare seeking. Additionally,
health education sessions that emphasized the cause, the
availability of treatment, and the curability of tuberculosis
should be designed and provided to raise awareness and
reduce the TB-associated stigma. Furthermore, as this is a
cross-sectional study, future studies are essential that use
stronger designs and can establish causality among different
factors. Lastly, use of a standard definition of delay might
permit for more suitable assessments.
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